The CDC designed a tool to help identify a facility's level of maternal and neonatal care. Rear Admiral Wanda Barfield, MD, MPH, director of the Division of Reproductive Health for the CDC, discusses how it works to assess risk-appropriate care.
Transcript
The Centers for Disease Control and Prevention designeed LOCATe, a tool to help identify a facility's level of maternal and neonatal care. Can you discuss this tool and how it works to assess risk-appropriate care? What outcomes have you seen after the utilization of the LOCATe tool, and how does it improve maternal and child health?
So, the LOCATe tool is just that, it's a tool that helps public health leaders, as well as providers, to identify appropriate levels of care. It's an opportunity to utilize it on a broader scale, and to make general assessments about whether facilities are a certain level. If they're within a certain level, are they able to provide care appropriate for the population that they're serving.
LOCATe is an opportunity for health departments, as well as clinical providers, to assess the levels of care. That includes equipment, facilities, it also includes the skills within a particular facility to see whether it's a highest level of care, or a more basic level of care.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More